We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$233B
AUM Growth
-$27.8B
Cap. Flow
-$12.3B
Cap. Flow %
-5.26%
Top 10 Hldgs %
23.23%
Holding
2,904
New
60
Increased
1,374
Reduced
786
Closed
124

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$646M
2
ADP icon
Automatic Data Processing
ADP
+$510M
3
BIDU icon
Baidu
BIDU
+$349M
4
TSLA icon
Tesla
TSLA
+$320M
5
NVDA icon
NVIDIA
NVDA
+$261M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Healthcare 13.27%
3 Financials 12.05%
4 Consumer Discretionary 11.3%
5 Communication Services 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZIP icon
2551
ZipRecruiter
ZIP
$339M
$290K ﹤0.01%
+12,600
New +$273K
ORGO icon
2552
Organogenesis Holdings
ORGO
$324M
$288K ﹤0.01%
37,740
HVT icon
2553
Haverty Furniture Companies
HVT
$418M
$287K ﹤0.01%
10,473
-6,699
-39% -$195K
BTAI icon
2554
BioXcel Therapeutics
BTAI
$24.8M
$287K ﹤0.01%
857
IMVT icon
2555
Immunovant
IMVT
$7.93B
$286K ﹤0.01%
51,942
CNXN icon
2556
PC Connection
CNXN
$2.09B
$284K ﹤0.01%
5,425
NGM
2557
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$284K ﹤0.01%
18,629
TCS
2558
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$282K ﹤0.01%
2,303
CRBU icon
2559
Caribou Biosciences
CRBU
$146M
$278K ﹤0.01%
+30,300
New +$319K
EHTH icon
2560
eHealth
EHTH
$41.9M
$275K ﹤0.01%
22,128
-8,566
-28% -$148K
HSTM icon
2561
HealthStream
HSTM
$863M
$274K ﹤0.01%
13,746
-9,560
-41% -$216K
HIPO icon
2562
Hippo Holdings
HIPO
$777M
$273K ﹤0.01%
5,480
RBBN icon
2563
Ribbon Communications
RBBN
$386M
$271K ﹤0.01%
87,846
+1,216
+1% +$4.98K
WGS icon
2564
GeneDx Holdings
WGS
$1.89B
$271K ﹤0.01%
2,679
OMER icon
2565
Omeros
OMER
$845M
$270K ﹤0.01%
44,932
BROS icon
2566
Dutch Bros
BROS
$8.86B
$269K ﹤0.01%
+4,871
New +$249K
SKYW icon
2567
Skywest
SKYW
$4.35B
$269K ﹤0.01%
9,313
-8,256
-47% -$270K
LOCO icon
2568
El Pollo Loco
LOCO
$503M
$268K ﹤0.01%
23,101
AHT
2569
Ashford Hospitality Trust
AHT
$20.8M
$266K ﹤0.01%
2,610
+740
+40% +$66K
AKRO
2570
DELISTED
Akero Therapeutics
AKRO
$265K ﹤0.01%
+18,640
New +$326K
RMR icon
2571
The RMR Group
RMR
$335M
$263K ﹤0.01%
8,466
+271
+3% +$8.46K
PAHC icon
2572
Phibro Animal Health
PAHC
$1.5B
$261K ﹤0.01%
13,078
+3,144
+32% +$63.5K
KOP icon
2573
Koppers
KOP
$946M
$259K ﹤0.01%
9,415
+273
+3% +$8.06K
BBIG
2574
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$259K ﹤0.01%
5,939
VBIV
2575
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$257K ﹤0.01%
5,170

Similar funds

UBS AM's Q1 2022 Portfolio in Review

As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS AM opened a new position in Baidu worth $306M.

  • UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
  • UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
  • UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
  • UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
  • UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
  • UBS AM opened 60 new positions and closed 124 in Q1 2022.
  • UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.

Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.